Trial · NCT02163499
Adverse events286
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 286
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Acute Phase: ZS | 0 | 751 | |
| other | Anaemia | Blood and lymphatic system disorders | Extended Dosing Phase: ZS | 42 | 746 | |
| other | Hypertension | Vascular disorders | Acute Phase: ZS | 1 | 751 | |
| other | Hypertension | Vascular disorders | Extended Dosing Phase: ZS | 78 | 746 | |
| other | Oedema peripheral | General disorders | Acute Phase: ZS | 1 | 751 | |
| other | Oedema peripheral | General disorders | Extended Dosing Phase: ZS | 72 | 746 | |
| other | Nausea | Gastrointestinal disorders | Acute Phase: ZS | 4 | 751 | |
| other | Nausea | Gastrointestinal disorders | Extended Dosing Phase: ZS | 56 | 746 | |
| other | Constipation | Gastrointestinal disorders | Acute Phase: ZS | 2 | 751 | |
| other | Constipation | Gastrointestinal disorders | Extended Dosing Phase: ZS | 46 | 746 | |
| other | Urinary tract infection | Infections and infestations | Acute Phase: ZS | 3 | 751 | |
| other | Urinary tract infection | Infections and infestations | Extended Dosing Phase: ZS | 55 | 746 | |
| other | Upper respiratory infection | Infections and infestations | Acute Phase: ZS | 0 | 751 | |
| other | Upper respiratory infection | Infections and infestations | Extended Dosing Phase: ZS | 37 | 746 | |
| serious | Neuropathic arthropathy | Musculoskeletal and connective tissue disorders | Acute Phase: ZS | 0 | 751 | |
| serious | Neuropathic arthropathy | Musculoskeletal and connective tissue disorders | Extended Dosing Phase: ZS | 1 | 746 | |
| serious | Lower limb fracture | Injury, poisoning and procedural complications | Acute Phase: ZS | 0 | 751 | |
| serious | Lower limb fracture | Injury, poisoning and procedural complications | Extended Dosing Phase: ZS | 1 | 746 | |
| serious | Pneumonia | Infections and infestations | Acute Phase: ZS | 0 | 751 | |
| serious | Pneumonia | Infections and infestations | Extended Dosing Phase: ZS | 14 | 746 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02163499/events